36 min listen
Identify and Act, Part 2: What's New in Managing Homozygous Familial Hypercholesterolemia?
Identify and Act, Part 2: What's New in Managing Homozygous Familial Hypercholesterolemia?
ratings:
Length:
54 minutes
Released:
Mar 29, 2024
Format:
Podcast episode
Description
Did you know that greatly reduced low-density lipoprotein (LDL) receptor activity in homozygous familial hypercholesterolemia (HoFH) leads to severely elevated LDL-cholesterol (LDL-C) levels from birth causing very early onset of cardiovascular disease (CVD) events? Credit available for this activity expires: 3/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000494?ecd=bdc_podcast_libsyn_mscpedu
Released:
Mar 29, 2024
Format:
Podcast episode
Titles in the series (100)
Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations: Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)? Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME